We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Infusion Pump Market Worth $7 Billion in 2015

By HospiMedica International staff writers
Posted on 04 Jul 2016
The global market for infusion medical pumps grew at an average rate of 2.6% from $6.1 billion in 2010 to almost $7 billion in 2015. More...
These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

Infusion pumps are used to provide necessary fluids, basic fluids for hydration as well as pain medications, antibiotics, or chemotherapy, to a patient’s circulatory system. They are mostly used in emergency departments, operating rooms, and neonate departments of hospitals, long-term care settings, physician’s offices, and home settings when continuous monitoring and treatment is expensive, impractical, or unreliable.

Medical infusion pumps are divided in six categories, namely large volume infusion pumps, ambulatory infusion pumps, syringe infusion pumps, insulin infusion pumps, implantable infusion pumps, and enteral feeding pumps. Large volume infusion pumps are used for delivery of nutrients and hydration products to patients, while ambulatory infusion pumps are commonly used in hospital, surgical, home and emergency medical facilities. Syringe pumps are used for the delivery of precise amounts of fluid and drugs to patients, while insulin infusion pumps are employed for diabetes management in patients. Implantable infusion pumps are used for specific drugs, dosages, and routes of administration, while enteral feeding pumps are uses to provide liquid nutrition into the digestive system.

“Some areas of the market continue to display strong growth, including insulin infusion pumps and ambulatory enteral feeding pumps,” said Bruce Carlson, Publisher of Kalorama Information. “Each segments of the infusion pumps market has shown an increase, each segment experiencing a range of market drivers.”

“Smart” pump technologies and other advanced features have become a key driver of the infusion pump market. A smart pump is equipped with intravenous (IV) medication error-prevention software to alert operators when a pump setting is programmed outside of pre-configured limits. This, coupled with the growth in wireless capabilities, and advanced connectivity and integration is driving end users to evaluate device inventory and integrate advanced devices.

Some of the leading competitors and niche product developers include Baxter (Baxter, Deerfield, IL, USA), B. Braun (Melsungen, Germany), Halyard Health (Alpharetta, GA, USA), Johnson & Johnson (J&J, New Brunswick, NJ, USA), Medtronic (Dublin, Ireland), and Roche (Basel, Switzerland).

Related Links:
Kalorama Information
Baxter
Johnson & Johnson
Roche

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Adhesive
MED 5570U
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.